ID   UBD_RAT                 Reviewed;         161 AA.
AC   Q921A3; Q6MFX3;
DT   13-SEP-2004, integrated into UniProtKB/Swiss-Prot.
DT   01-DEC-2001, sequence version 1.
DT   02-OCT-2024, entry version 109.
DE   RecName: Full=Ubiquitin D;
DE   AltName: Full=Diubiquitin;
DE   AltName: Full=Ubiquitin-like protein FAT10;
GN   Name=Ubd; Synonyms=Fat10;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RA   Walter L.;
RT   "Characterization of the rat Ubd gene.";
RL   Submitted (JUN-2001) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=Brown Norway;
RX   PubMed=15060004; DOI=10.1101/gr.1987704;
RA   Hurt P., Walter L., Sudbrak R., Klages S., Mueller I., Shiina T., Inoko H.,
RA   Lehrach H., Guenther E., Reinhardt R., Himmelbauer H.;
RT   "The genomic sequence and comparative analysis of the rat major
RT   histocompatibility complex.";
RL   Genome Res. 14:631-639(2004).
CC   -!- FUNCTION: Ubiquitin-like protein modifier which can be covalently
CC       attached to target protein and subsequently leads to their degradation
CC       by the 26S proteasome, in a NUB1-dependent manner. Probably functions
CC       as a survival factor. Promotes the expression of the proteasome subunit
CC       beta type-9 (PSMB9/LMP2). Regulates TNF-alpha-induced and LPS-mediated
CC       activation of the central mediator of innate immunity NF-kappa-B by
CC       promoting TNF-alpha-mediated proteasomal degradation of ubiquitinated-
CC       I-kappa-B-alpha. Required for TNF-alpha-induced p65 nuclear
CC       translocation in renal tubular epithelial cells (RTECs). May be
CC       involved in dendritic cell (DC) maturation, the process by which
CC       immature dendritic cells differentiate into fully competent antigen-
CC       presenting cells that initiate T-cell responses. Mediates mitotic non-
CC       disjunction and chromosome instability, in long-term in vitro culture
CC       and cancers, by abbreviating mitotic phase and impairing the
CC       kinetochore localization of MAD2L1 during the prometaphase stage of the
CC       cell cycle. May be involved in the formation of aggresomes when
CC       proteasome is saturated or impaired. Mediates apoptosis in a caspase-
CC       dependent manner, especially in renal epithelium and tubular cells
CC       during renal diseases (By similarity). {ECO:0000250}.
CC   -!- SUBUNIT: Interacts directly with the 26S proteasome. The interaction
CC       with NUB1 via the N-terminal ubiquitin domain facilitates the linking
CC       of UBD-conjugated target protein to the proteasome complex and
CC       accelerates its own degradation and that of its conjugates. Interacts
CC       (via ubiquitin-like 1 domain) with the spindle checkpoint protein
CC       MAD2L1 during mitosis. Present in aggresomes of proteasome inhibited
CC       cells. Interacts with HDAC6 under proteasome impairment conditions.
CC       Forms a thioester with UBA6 in cells stimulated with tumor necrosis
CC       factor-alpha (TNFa) and interferon-gamma (IFNg). Interacts with SQSTM1
CC       and TP53/p53 (By similarity). {ECO:0000250|UniProtKB:O15205}.
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000250}. Cytoplasm {ECO:0000250}.
CC       Note=Accumulates in aggresomes under proteasome inhibition conditions.
CC       {ECO:0000250}.
CC   -!- INDUCTION: Possible cell-cycle regulation with highest expression
CC       during the S-phase (at protein level). Probably rapidly degraded by the
CC       proteasome.
CC   -!- PTM: Can be acetylated. {ECO:0000250}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AJ312394; CAC42833.1; -; mRNA.
DR   EMBL; BX883052; CAE84074.1; -; Genomic_DNA.
DR   RefSeq; NP_445751.2; NM_053299.2.
DR   AlphaFoldDB; Q921A3; -.
DR   SMR; Q921A3; -.
DR   STRING; 10116.ENSRNOP00000000995; -.
DR   PhosphoSitePlus; Q921A3; -.
DR   PaxDb; 10116-ENSRNOP00000000995; -.
DR   GeneID; 29168; -.
DR   KEGG; rno:29168; -.
DR   UCSC; RGD:69418; rat.
DR   AGR; RGD:69418; -.
DR   CTD; 10537; -.
DR   RGD; 69418; Ubd.
DR   eggNOG; KOG0001; Eukaryota.
DR   InParanoid; Q921A3; -.
DR   OrthoDB; 5315604at2759; -.
DR   PhylomeDB; Q921A3; -.
DR   Reactome; R-RNO-8951664; Neddylation.
DR   PRO; PR:Q921A3; -.
DR   Proteomes; UP000002494; Unplaced.
DR   GO; GO:0016235; C:aggresome; ISS:UniProtKB.
DR   GO; GO:0005737; C:cytoplasm; ISS:UniProtKB.
DR   GO; GO:0005634; C:nucleus; ISS:UniProtKB.
DR   GO; GO:0070628; F:proteasome binding; ISS:UniProtKB.
DR   GO; GO:0070842; P:aggresome assembly; ISS:UniProtKB.
DR   GO; GO:0043011; P:myeloid dendritic cell differentiation; ISS:UniProtKB.
DR   GO; GO:0043065; P:positive regulation of apoptotic process; ISS:UniProtKB.
DR   GO; GO:0043123; P:positive regulation of canonical NF-kappaB signal transduction; ISS:UniProtKB.
DR   GO; GO:0016567; P:protein ubiquitination; ISS:UniProtKB.
DR   GO; GO:1901990; P:regulation of mitotic cell cycle phase transition; ISS:UniProtKB.
DR   GO; GO:0001666; P:response to hypoxia; IEP:RGD.
DR   GO; GO:0002931; P:response to ischemia; IEP:RGD.
DR   GO; GO:0034612; P:response to tumor necrosis factor; ISO:RGD.
DR   GO; GO:0034341; P:response to type II interferon; ISO:RGD.
DR   GO; GO:0006511; P:ubiquitin-dependent protein catabolic process; ISS:UniProtKB.
DR   CDD; cd17053; Ubl2_FAT10; 1.
DR   InterPro; IPR000626; Ubiquitin-like_dom.
DR   InterPro; IPR029071; Ubiquitin-like_domsf.
DR   InterPro; IPR042969; Ubiquitin_D.
DR   InterPro; IPR019956; Ubiquitin_dom.
DR   PANTHER; PTHR47731; UBIQUITIN D; 1.
DR   PANTHER; PTHR47731:SF1; UBIQUITIN D; 1.
DR   Pfam; PF00240; ubiquitin; 2.
DR   PRINTS; PR00348; UBIQUITIN.
DR   SMART; SM00213; UBQ; 2.
DR   SUPFAM; SSF54236; Ubiquitin-like; 2.
DR   PROSITE; PS50053; UBIQUITIN_2; 2.
PE   1: Evidence at protein level;
KW   Acetylation; Cytoplasm; Nucleus; Reference proteome; Repeat;
KW   Ubl conjugation pathway.
FT   CHAIN           1..161
FT                   /note="Ubiquitin D"
FT                   /id="PRO_0000114895"
FT   DOMAIN          3..77
FT                   /note="Ubiquitin-like 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00214"
FT   DOMAIN          86..159
FT                   /note="Ubiquitin-like 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00214"
FT   SITE            160..161
FT                   /note="Activation by thioester intermediate formation with
FT                   UBA6"
FT                   /evidence="ECO:0000250"
FT   CONFLICT        9
FT                   /note="R -> H (in Ref. 2; CAE84074)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        127
FT                   /note="I -> F (in Ref. 2; CAE84074)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   161 AA;  17983 MW;  5BAB9D199885A0D8 CRC64;
     MASCVCVVRS EQWPLMTFDT TMSDKVKKIN EHIRSQTKVS VQDQILLLDS KILKPHRALS
     SYGIDKENTI HLTLKVVKPS DEELPLSLVE SGDEGQRHLL RVRRSSSVAQ VKEMIENVTA
     VPPKKQIVNC NGKRLEDGKI MADYNIKSGS LLFLTAHCIG G
//
